Floatz logo

Atumelnant

Classic Congenital Adrenal Hyperplasia

Crinetics Pharmaceuticals Inc.Small moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Classic Congenital Adrenal Hyperplasia cohort.

Asset / SponsorPhaseRating
Crinecerfont
Neurocrine Biosciences
Phase 2B
Tildacerfont
Spruce Biosciences
Phase 2CC

Same molecule, other indications

Atumelnant is also rated in:

congenital adrenal hyperplasiaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →